BACK

Hepatology References

REFERENCES IN CHRONOLOGICAL ORDER

(Updated on 25 January 2012)

Year of publication:
» 2012
» 2011
» 2010
» 2009
» 2008
» 2007
» 2004 – 2006

Antoine DJ, Jenkins RE, Dear JW, Williams DP, McGill MR, Sharpe MR, Craig DG, Simpson KJ, Jaeschke H, Kevin Park B (2012)
Molecular forms of HMGB1 and Keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity
J Hepatol 2012, , [Epub ahead of print]
»Abstract

Koo JH, Lee MH, Kim SS, Kim DH, Kim IS, Lee KM, Yoo BM, Lee KJ, Kim JH, Cho SW, Cheong JY (2012)
Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy.
Clin Biochem. 2012, 45(1-2), 31-6
»Abstract

Alkhouri N, Carter-Kent C, Feldstein AE (2011)
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
Expert Rev. Gastroenterol. Hepatol. 2011, 5(2), 201–212
»Abstract

Connoy A, Turner J, Núñez M. (2011)
Levels of Serum Markers of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis C Virus Infection According to HIV Status and Antiretroviral Use.
AIDS Res Hum Retroviruses. 2011, 27(7), 719-25
»Abstract

Dasarathy S, Yang Y, McCullough AJ, Marczewski S, Bennett C, Kalhan SC (2011)
Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis
Eur J Gastroenterol Hepatol. 2011, 23(5), 382-8
»Abstract

Dowman JK, Tomlinson JW, Newsome PN. (2011)
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Aliment Pharmacol Ther. 2011, 33(5), 525-40
»Abstract

Farnik H, Lange CM, Hofmann WP, Berger A, Allwinn R, Welker MW, Trojan J, Sarrazin C, Herrmann E, Zeuzem S, Kronenberger B (2011)
Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B.
J Clin Virol. 2011, 52(3), 204-9
»Abstract

Gieseler RK, Marquitan G, Schlattjan M, Sowa JP, Bechmann LP, Timm J, Roggendorf M, Gerken G, Friedman SL, Canbay A. (2011)
Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C.
J Viral Hepat. 2011, 18(11), 760-7
»Abstract

Herzer K, Kneiseler G, Bechmann LP, Post F, Schlattjan M, Sowa JP, Neumann T, Marggraf G, Erbel R, Gerken G, Canbay A, Jochum C. (2011)
Onset of heart failure determines the hepatic cell death pattern.
Ann Hepatol. 2011 Apr 2011, 10(2), 174-9
»Abstract

Janciauskiene S, Wallmark A, Piitulainen E, Köhnlein T, Welte T, Sveger T. (2011)
Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency.
Eur J Gastroenterol Hepatol. 2011, 23(8), 716-20
»Abstract

Jazwinski AB, Thompson AJ, Clark PJ, Naggie S, Tillmann HL, Patel K (2011)
Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis
Journal of Viral Hepatitis 2011, ,

Joka D, Wahl K, Moeller S, Schlue J, Vaske B, Bahr MJ, Manns MP, Schulze-Osthoff K, Bantel H (2011)
Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.
Hepatology 2011, , [Epub ahead of print]
»Abstract

Kälsch J, Bechmann LP, Kälsch H, Schlattjan M, Erhard J, Gerken G, Canbay A (2011)
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients
J Nutr Metab. 2011, , 2011:369168
»Abstract

Lavallard VJ, Bonnafous S, Patouraux S, Saint-Paul MC, Rousseau D, Anty R, Le Marchand-Brustel Y, Tran A, Gual P. (2011)
Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.
PLoS One. 2011, 6(3), e17599.
»Abstract

Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M (2011)
Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease
Acta Biochim Pol 2011, 58(4), 563-6
»Abstract

Miller MH, Ferguson MA, Dillon JF (2011)
Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease
Liver Int. 2011, 31(4), 461-73
»Abstract

Musso G, Gambino R, Cassader M, Pagano G (2011)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Ann Med. 2011, 43(8), 617-49
»Abstract

Ratziu V, Sheikh MY, Sanyal AJ, Lim JK, Conjeevaram H, Chalasani N, Abdelmalek M, Bakken A, Renou C, Palmer M, Levine RA, Bhandari BR, Cornpropst M, Liang W, King B, Mondou E, Rousseau FS, McHutchison J, Chojkier M (2011)
A Phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.
Hepatology 2011, , [Epub ahead of print]
»Abstract

Richard J, Lingvay I. (2011)
Hepatic steatosis and Type 2 diabetes: current and future treatment considerations.
Expert Rev Cardiovasc Ther. 2011 Mar;9(3):321-8. 2011, 9(3), 321-8
»Abstract

Tamimi TI, Elgouhari HM, Alkhouri N, Yerian LM, Berk MP, Lopez R, Schauer PR, Zein NN, Feldstein AE. (2011)
An apoptosis panel for nonalcoholic steatohepatitis diagnosis.
J Hepatol. 2011, 54(6), 1224-9.
»Abstract

Yilmaz Y, (2011)
Cytokeratins in hepatitis
Clin Chim Acta 2011, 412(23-24), 2031-6
»Abstract

Anty R, Iannelli A, Patouraux S, Bonnafous S, Lavallard VJ, Senni-Buratti M, Amor IB, Staccini-Myx A, Saint-Paul MC, Berthier F, Huet PM, Le Marchand-Brustel Y, Gugenheim J, Gual P, Tran A. (2010)
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.
Aliment Pharmacol Ther. 2010, 32(11-12), 1315-22
»Abstract

Bechmann LP, Jochum C, Kocabayoglu P, Sowa JP, Kassalik M, Gieseler RK, Saner F, Paul A, Trautwein C, Gerken G, Canbay A. (2010)
Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury.
J Hepatol. 2010, 53(4), 639-47
»Abstract

Bechmann LP, Gieseler RK, Sowa JP, Kahraman A, Erhard J, Wedemeyer I, Emons B, Jochum C, Feldkamp T, Gerken G, Canbay A. (2010)
Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis.
Liver Int. 2010, 30(6), 850-9
»Abstract

Cave M, Falkner KC, Ray M, Joshi-Barve S, Brock G, Khan R, Bon Homme M, McClain CJ. (2010)
Toxicant-associated steatohepatitis in vinyl chloride workers.
Hepatology. 2010, 51(2), 474-81
»Abstract

Civera M, Urios A, Garcia-Torres ML, Ortega J, Martinez-Valls J, Cassinello N, del Olmo JA, Ferrandez A, Rodrigo JM, Montoliu C. (2010)
Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity.
Diabetes Metab Res Rev. 2010, 26(3), 187-92
»Abstract

Dechêne A, Sowa JP, Gieseler RK, Jochum C, Bechmann LP, El Fouly A, Schlattjan M, Saner F, Baba HA, Paul A, Dries V, Odenthal M, Gerken G, Friedman SL, Canbay A. (2010)
Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation.
Hepatology 2010, 52(3), 1008-16
»Abstract

Eren F, Yilmaz Y, Kose S, Ozdemir FT, Yonal O, Kurt R, Ozdogan O, Avsar E. (2010)
Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.
Clin Chim Acta. 2010, 411(23-24), 2029-32
»Abstract

Estep JM, Birerdinc A, Younossi Z. (2010)
Non-invasive diagnostic tests for non-alcoholic fatty liver disease.
Curr Mol Med. 2010, 10(2), 166-172
»Abstract

Feldstein AE, Nobili V. (2010)
Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children.
J Pediatr Gastroenterol Nutr. 2010, 51(4), 378-9
»Abstract

Fitzpatrick E, Mitry RR, Quaglia A, Hussain MJ, DeBruyne R, Dhawan A. (2010)
Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD.
J Pediatr Gastroenterol Nutr. 2010, 51(4), 500-6
»Abstract

Gieseler RK, Marquitan G, Schlattjan M, Sowa JP, Bechmann LP, Timm J, Roggendorf M, Gerken G, Friedman SL, Canbay A. (2010)
Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C.
J Viral Hepat. 2010, , [Epub ahead of print]
»Abstract

Kahraman A, Schlattjan M, Kocabayoglu P, Yildiz-Meziletoglu S, Schlensak M, Fingas CD, Wedemeyer I, Marquitan G, Gieseler RK, Baba HA, Gerken G, Canbay A. (2010)
Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.
Hepatology 2010, 51(1), 92-102
»Abstract

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos DG, Margariti K, Archimandritis AJ. (2010)
Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.
J Clin Gastroenter 2010, 44(4), e87-95
»Abstract

Paschos KA, Charsou C, Constantinidis TC, Anagnostoulis S, Lambropoulou M, Papachristou F, Simopoulos K, Chatzaki E. (2010)
Corticotropin-releasing hormone receptors mediate opposing effects in cholestasis-induced liver cell apoptosis.
Endocrinology. 2010, 151(4), 1704-12
»Abstract

Samuel D, Ichai P. (2010)
Prognosis indicator in acute liver failure: Is there a place for cell death markers?
J Hepatol. 2010, 53(4), 593-5
»Abstract

Sgier C, Müllhaupt B, Gerlach T, Moradpour D, Negro F, Malé PJ, Heim MH, Malinverni R, Cerny A, Dufour JF. (2010)
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.
J Viral Hepat. 2010, 17(12), 845-50
»Abstract

Tabuchi M, Tomioka K, Kawakami T, Murakami Y, Hiramatsu M, Itoshima T, Sugawara S, Kawashima A, Okita M, Tsukamoto I. (2010)
Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD).
J Nutr Sci Vitaminol (Tokyo). 2010, 56(5), 271-8.
»Abstract

Tan S, Bechmann LP, Benson S, Dietz T, Eichner S, Hahn S, Janssen OE, Lahner H, Gerken G, Mann K, Canbay A. (2010)
Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome.
J Clin Endocrinol Metab. 2010, 95(1), 343-8
»Abstract

Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M, Nagaya T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E, Sano K. (2010)
Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
J Clin Gastroenterol. 2010, 44(6), 440-7
»Abstract

Ulukaya S, Ulukaya E, Alper I, Yilmaztepe-Oral A, Kilic M. (2010)
Soluble cytokeratin 18 biomarkers may provide information on the type of cell death during early ischemia and reperfusion periods of liver transplantation.
Clin Transplant. 2010, 24(6), 848-54
»Abstract

Valva P, De Matteo E, Galoppo MC, Gismondi MI, Preciado MV. (2010)
Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis.
J Med Virol. 2010, 82(6), 949-57
»Abstract

Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL. (2010)
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Gut. 2010, 59(7), 969-74
»Abstract

Younossi ZM, Page S, Rafiq N, Birerdinc A, Stepanova M, Hossain N, Afendy A, Younoszai Z, Goodman Z, Baranova A. (2010)
A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis.
Obes Surg. 2010, 21(4), 431-9
»Abstract

Balmer ML, Siegrist K, Zimmermann A, Dufour JF (2009)
Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis.
Liver Int. 2009, 29(8), 1184-8
»Abstract

Feldstein A, Wickowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. (2009)
Cytokeratin-18 fragment levels as noninvasive biomarker for nonalcoholic steatohepatitis: A multicenter validation study.
Hepatology 2009, 50(4), 1072-8
»Abstract

Feldstein A, Kleiner D, Kravetz D, Buck M. (2009)
Severe Hepatocellular Injury With Apoptosis Induced by a Hepatitis C Polymerase Inhibitor
J Clin Gastroenterol 2009, 43(4), 1
»Abstract

Hashimoto E, Farrell GC. (2009)
Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
J Gastroenterol Hepatol 2009, 24(4), 501-3
»Abstract

Jochum C, Gieseler RK, Gawlista I, Fiedler A, Manka P, Saner FH, Roggendorf M, Gerken G, Canbay A. (2009)
Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae.
Digestion. 2009, 80(4), 235-40
»Abstract

Ludmila Vîksna, Jâzeps Keiðs, Artûrs Soèòevs, Baiba Rozentâle, Mâra Pilmane, Natâlija Sevastjanova, Inita Buiíe, Agita Jçruma, Elena Eglîte, Kristîne Âbeltiòa, and Valentîna Sondore (2009)
Novel Laboratory Tests in Assessment of Liver Function in Acute and Chronic Liver Diseases
Proceedings of the Latvian Academy of Sciences 2009, 4(5), 228-233

Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, Byrnes V, Afdhal N. (2009)
The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.
J Gastroenterol Hepatol 2009, 24(4), 564-8
»Abstract

Musso G, Gambino R, Pacini G, De Michieli F, Cassader M. (2009)
Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
Am J Clin Nutr. 2009, 89(2), 558-67
»Abstract

Musso G, Gambino R, Pacini G, Pagano G, Durazzo M, Cassader M. (2009)
Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH.
Hepatology. 2009, 49(2), 426-35.
»Abstract

To the editor: Bantel H, Bahr MJ, Schulze-Osthoff K. (2009)
An apoptosis biomarker for prediction of nonalcoholic steatohepatitis.
Hepatology 2009, 50(3), 991
»Abstract

To the editor: Yilmaz Y, (2009)
Defragmenting the noninvasive diagnosis of nonalcoholic steatohepatitis: Hopes from cytokeratin-18
Hepatology 2009, 50(3), 990-1
»Abstract

Wedemeyer I, Bechmann LP, Odenthal M, Jochum C, Marquitan G, Drebber U, Gerken G, Gieseler RK, Dienes HP, Canbay A. (2009)
Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C.
J Hepatol. 2009, 50(1), 140-9
»Abstract

Yilmaz Y, (2009)
Systematic review: caspase-cleaved fragments of cytokeratin 18 – the promises and challenges of a biomarker for chronic liver disease
Aliment Pharmacol Ther 2009, 30(11-12), 1103-9
»Abstract

Yilmaz Y, Kedrah AE, Ozdogan O. (2009)
Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis
World J Gastroenterol 2009, 15(35), 4387-91
»Abstract

Diab DL, Yerian L, Schauer P, Kashyap SR, Lopez R, Hazen SL, Feldstein AE. (2008)
Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.
Clin Gastroenterol Hepatol. 2008, 6(11), 1249-54
»Abstract

Greystoke A, Cummings J, Ward T, Simpson K, Renehan A, Butt F, Moore D, Gietema J, Blackhall F, Ranson M, Hughes A, Dive C. (2008)
Optimisation of circulating biomarkers of cell death for routine clinical use.
Ann Oncol. 2008, 19(5), 990-5
»Abstract

Papatheodoridis GV, Hadizyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis E, Archimandritis AJ. (2008)
Serum Apoptotic Caspase Activity As A Marker Of Severity In Hbeag‑Negative Chronic Hepatitis B Virus Infection
Gut. 2008, 57 (4), 500-6
»Abstract

Wieckowska A, Feldstein AE. (2008)
Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.
Semin Liver Dis. 2008, 28(4), 386-95
»Abstract

Volkmann X, Anstaett, M., Hadem, J., Stiefel, P., Bahr, M J., Frank, L., Manns, M P., Schulze-Osthoff, K., Bantel, H. (2008)
Caspase activation is associated with spontaneous recovery from acute liver failure.
Hepatology 2008, 22237, 1624-1633
»Abstract

Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, McClain CJ. (2008)
Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.
J Pediatr Gastroenterol Nutr 2008, 47(4), 481-5
»Abstract

Younossi ZM, (2008)
Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Aliment Pharmacol Ther. 2008, 28(1), 2-12
»Abstract

Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A. (2008)
A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH).
Obes Surg 2008, ,
»Abstract

Bechmann L P, Guido Marquitan, Christoph Jochum, Fuat Saner, Guido Gerken, Ali Canbay (2007) (2007)
Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute‑on‑chronic liver failure
Liver International 2007, 2007, 1478-3231
»Abstract

Hetz H, Hoetzenecker K, Hacker S, Faybik P, Pollreisz A, Moser B, Roth G, Hoetzenecker W, Lichtenauer M, Klinger M, Krenn CG, Ankersmit HJ (2007)
Caspase-cleaved cytokeratin 18 and 20 S proteasome in liver degeneration.
J Clin Lab Anal 2007, 21(5), 277-81
»Abstract

Neuman M, Benhamou JP, Marcellin P, Valla D, Malkiewicz IM, Katz GG, Trepo C, Bourliere M, Cameron RG, Cohen L, Morgan M, Schmilovitz-Weiss H, Ben-Ari Z. (2007)
Cytokine – chemokine and apoptotic signatures in patients with hepatitis C.
Transl Res. 2007, 149(3), 126-36
»Abstract

Rutherford AE, Hynan LS, Borges CB, Forcione DG, Blackard JT, Lin W, Gorman AR, Shaikh OS, Reuben A, Harrison E, Reddy KR, Le WM, Chung RT (2007)
Serum apoptosis markers in acute liver failure: a pilot study.
Clin Gastroenterol Hepatol. 2007, 5(12), 1477-83
»Abstract

Tumurbaatar B, Sun Y, Chan T, Sun J. (2007)
Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice
J Virol Methods 2007, 146 (1-2), 5-13
»Abstract

Wieckowska A, McCullough AJ, Feldstein AE (2007)
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future.
Hepatology 2007, 46(2), 582-589
»Abstract

Yagmur E, Trautwein C, Leers MP, Gressner AM, Tacke F (2007)
Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation
Clin Biochem 2007, 40(9-10), 651-5
»Abstract

Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak SG. (2007)
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.
World J Gastroenterol 2007, 13(6), 837-44
»Abstract

Bantel H, Lugering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze‑Osthoff K. (2004)
Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.
Hepatology 2004, 40, 1078-1087
»Abstract

Kronenberger B, Wagner M, Herrmann E, Mihm U, Piiper A, Sarrazin C, Zeuzem S. (2005)
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
J Viral Hepat. 2005, 12(3), 307-14
»Abstract

Ramskogler K, Brunner M, Hertling I, Dvorak A, Kapusta N, Krenn C, Moser B, Roth G, Lesch OM, Ankersmit HJ, Walter H. (2004)
CDT values are not influenced by epithelial cell apoptosis in chronic alcoholic patients-preliminary results.
Alcohol Clin Exp Res. 2004, 28(9), 1396-8
»Abstract

Seidel N, Volkmann X, Langer F, Flemming P, Manns MP, Schulze-Osthoff K, Bantel H. (2005)
The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum
Hepatology 2005, 42, 113-120
»Abstract

Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE (2006)
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
Hepatology 2006, 44(1), 27-33
»Abstract

Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns MP, Schulze-Osthoff K, Bantel H. (2006) (2006)
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.
Hepatology 2006, 43(6), 1311-1316
»Abstract